Compound Q&A
What is the market or research trend for Birabresib (CAS: 202590-98-5)?
Answer
Birabresib (CAS: 202590-98-5) is gaining research interest due to its potential as a therapeutic agent in cancer treatment. Market trends indicate a growing focus on its development and clinical trials. Research trends highlight the exploration of its mechanism of action and its efficacy in combination therapies.
About
CAS No
202590-98-5
English Name
Birabresib
Molecular Formula
C25H22ClN5O2S
Molecular Weight
492 g/mol
SMILES
CC1=C(SC2=C1C(=NC(C3=NN=C(N32)C)CC(=O)NC4=CC=C(C=C4)O)C5=CC=C(C=C5)Cl)C
InChIKey
GNMUEVRJHCWKTO-FQEVSTJZSA-N
Last Updated: 2025-09-21 10:38
